Supernus SVP awarded options and RSUs

SUPERNUS PHARMACEUTICALS, INC. reported that SVP and Chief Technical Operations Officer Frank Mottola received new equity awards.

Rhea-AI Filing Summary

SUPERNUS PHARMACEUTICALS, INC. reported that SVP and Chief Technical Operations Officer Frank Mottola received new equity awards. He was granted employee stock options for 13,500 shares and 3,000 restricted stock units on February 18, 2026, both at a price of $0.00 per share.

The options vest in four equal annual installments beginning on February 18, 2027. Each restricted stock unit converts into one share of common stock and is settled in stock upon vesting, also in four equal annual installments starting on February 18, 2027. Following these grants, Mottola directly holds 15,724 shares of common stock, which include 228 shares acquired through the company’s employee stock purchase plan, along with the 13,500 options and 3,000 restricted stock units.

Insider Trade Summary

Grant/Award: 16,500 shares

Grant/Award 3 txns

Insider Mottola Frank

Role SVP, Chief Tech. Ops. Officer

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Option (Right to Buy)	13,500	$0.00	$0.00
Grant/Award	Restricted Stock Unit	3,000	$0.00	$0.00
holding	Common Stock	--	--	--

Holdings After Transaction: Employee Stock Option (Right to Buy) — 13,500 contracts (Direct); Restricted Stock Unit — 3,000 contracts (Direct); Common Stock — 15,724 shares (Direct)

Footnotes (4)

1. F1. Includes an aggregate of 228 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan.
2. F2. The option vests in four equal annual installments beginning on February 18, 2027.
3. F3. Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.
4. F4. These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 18, 2027.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did SUPN executive Frank Mottola report on this Form 4?

Frank Mottola reported receiving stock-based compensation, not open-market trades. He was granted employee stock options for 13,500 shares and 3,000 restricted stock units on February 18, 2026, both at an exercise or acquisition price of $0.00 per share as part of his compensation.

How many Supernus (SUPN) stock options and RSUs did Frank Mottola receive?

Frank Mottola received 13,500 employee stock options and 3,000 restricted stock units. These awards were granted on February 18, 2026, at a price of $0.00 per share, reflecting equity compensation rather than cash purchases. The positions are held directly in his name.

What is the vesting schedule for Frank Mottola’s new SUPN equity awards?

Both the 13,500 stock options and 3,000 restricted stock units vest in four equal annual installments. Vesting begins on February 18, 2027, and continues annually. Each restricted stock unit converts into one share of Supernus common stock and is settled in stock at vesting.

How many Supernus (SUPN) shares does Frank Mottola own after these transactions?

After these transactions, Frank Mottola directly holds 15,724 shares of Supernus common stock. This total includes 228 shares acquired through the company’s employee stock purchase plan, in addition to his newly granted 13,500 stock options and 3,000 restricted stock units.

What does each Supernus restricted stock unit granted to Frank Mottola represent?

Each restricted stock unit granted to Frank Mottola represents the right to receive one share of Supernus common stock upon vesting. The 3,000 units are settled in common stock in four equal annual installments, starting February 18, 2027, aligning compensation with long-term share ownership.

Did Frank Mottola buy or sell any Supernus (SUPN) shares on the open market?

The Form 4 does not show any open-market buys or sells by Frank Mottola. Instead, it reports stock option and restricted stock unit grants at $0.00 per share, along with updated direct ownership totals reflecting his existing holdings and plan-acquired shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/20/2026 - 04:46 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mottola Frank

(Last) (First) (Middle)

C/O SUPERNUS PHARMACEUTICALS, INC.,

9715 KEY WEST AVENUE

(Street)

ROCKVILLE MD 20850

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SUPERNUS PHARMACEUTICALS, INC. [ SUPN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Chief Tech. Ops. Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/18/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								15,724(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$50.2	02/18/2026		A		13,500		(2)	02/18/2036	Common Stock	13,500	$0	13,500	D
Restricted Stock Unit	(3)	02/18/2026		A		3,000		(4)	(4)	Common Stock	3,000	$0	3,000	D

Explanation of Responses:

1. Includes an aggregate of 228 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan.

2. The option vests in four equal annual installments beginning on February 18, 2027.

3. Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.

4. These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 18, 2027.

Remarks:

	/s/ Timothy C. Dec, as attorney-in-fact	02/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.